Form 8-K - Current report:
SEC Accession No. 0000885590-21-000025
Filing Date
2021-05-04
Accepted
2021-05-04 07:37:52
Documents
16
Period of Report
2021-05-04
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K bhc-20210504.htm   iXBRL 8-K 39866
2 EX-99.1 ex991-q1x2021.htm EX-99.1 460910
8 BHC LOGO image21a.jpg GRAPHIC 7860
  Complete submission text file 0000885590-21-000025.txt   698112

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT bhc-20210504.xsd EX-101.SCH 2439
4 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT bhc-20210504_cal.xml EX-101.CAL 726
5 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT bhc-20210504_def.xml EX-101.DEF 1662
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT bhc-20210504_lab.xml EX-101.LAB 25240
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT bhc-20210504_pre.xml EX-101.PRE 13191
9 EXTRACTED XBRL INSTANCE DOCUMENT bhc-20210504_htm.xml XML 11427
Mailing Address 2150 ST. ELZEAR BLVD. WEST LAVAL QUEBEC A8 H7L 4A8
Business Address 2150 ST. ELZEAR BLVD. WEST LAVAL QUEBEC A8 H7L 4A8 514-744-6792
Bausch Health Companies Inc. (Filer) CIK: 0000885590 (see all company filings)

IRS No.: 000000000 | State of Incorp.: NJ | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-14956 | Film No.: 21886017
SIC: 2834 Pharmaceutical Preparations